Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for matrix metalloproteinases
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Most Relevant Literature
- Mmp17-deficient mice exhibit heightened goblet cell effector expression in the colon and increased r…
- Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients.
- Elevated Plasma Levels of MT4-MMP and MT6-MMP; A New Observation in Patients with Thyroid Nodules.
- Dynamic expression of MMP28 during cranial morphogenesis.
- High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
Most Relevant Clinical Trials
- Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus
- Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
- The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary …
- Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
- Effect of Caffeic Acid Phenethyl Ester as a Matrix Metalloproteinase Inhibitor: Randomized Controlle…
